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Myoclonus epilepsy with ragged-red fibers (MERRFs), an inherited mitochondrial disorder, 
has characteristic morphological changes of ragged-red fibers (RRFs) in muscle biopsy, 
in the absence of which mitochondrial etiology is usually not considered in patients with 
phenotypes suggestive of MERRF. In these circumstances, MERRF can only be diag-
nosed using genetic analyses. The symptoms, pathological findings, and imaging results 
being age dependent, we can construct a protocol based on these characteristics to 
understand the disease’s natural course and to manage patients more effectively. The 
absence of RRFs should not preclude a MERRF diagnosis.
Keywords: myoclonus epilepsy with ragged-red fibers, mitochondria, ragged-red fibers, muscle, pathology, 
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INtRoDUCtIoN
Myoclonus epilepsy with ragged-red fibers (MERRF) is an inherited mitochondrial disorder charac-
terized by myoclonus epilepsy, ataxia, generalized seizures, and myopathy (1). Its estimated preva-
lence is about 1/400,000 in Northern Europe, although its prevalence in Asia is not established (2). 
MERRF affects the nervous system and skeletal muscles and is a genetically heterogeneous disease. 
Most patients have mutations in the mitochondrial deoxyribonucleic acid (mtDNA) tRNALys gene 
(3), with the A8344G mutation responsible for 80–90% of the cases (4, 5). Morphological changes 
have been observed in muscle biopsies from patients with MERRF, including a substantial propor-
tion of ragged-red fibers (RRFs), which are muscle fibers showing deficient cytochrome c oxidase 
(COX) activity, as well as the presence of COX-deficient vessels that are strongly immunoreactive for 
succinate dehydrogenase (6). In the absence of RFFs, mitochondrial etiology is not usually consid-
ered in patients with phenotypes suggestive of MERRF (7). We describe the case of a young patient 
with MERRF who carried the A8344G mutation, although muscle morphology and histochemical 
findings were normal.
Case
A boy who was 4 years and 11 months old was admitted to our hospital for repeated myoclonic 
seizure symptoms. He was born by Cesarean section at 40 weeks of gestational age and had a birth 
weight of 2,060 g. He was an only child to his parents, and was born with no specific family history. 
At 6 months of age, the patient was suspected of having hearing impairment, mild hypotonia, and 
Abbreviations: MERRF, myoclonus epilepsy with ragged-red fibers; RRFs, ragged-red fibers; mtDNA, mitochondrial deoxyri-
bonucleic acid; COX, cytochrome c oxidase; MRI, magnetic resonance imaging; EM, electron microscopy; MRC, mitochondrial 
respiratory chain; LM, light microscopy.
FIgURe 1 | (a,B) Axial and coronal FLAIR MRI at 4 years of age showed 
normal findings. (C,D) Axial T2-weighted MRI and coronal FLAIR MRI at 
6 years of age showed no significant interval change. FLAIR, fluid attenuated 
inversion recovery; MRI, magnetic resonance imaging.
taBle 1 | The mutant burden of mtDNA A8344G (%) in molecular genetic 
analysis.
skeletal muscle (%) skin fibroblast (%) Blood (%)
Patient 97 95 90
Patient’s mother Not available Not available 75
mtDNA, mitochondrial deoxyribonucleic acid.
FIgURe 2 | H&E (a) and Gomori-modified TRC (B) showed no ragged-red 
fiber (RRF). Ultrastructural study showed increased large mitochondria 
(megaconia) in the intermyofibrillar and subsarcolemmal area [(C) 10,000× 
and (D) 15,000×].
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delayed development. However, he was never examined by a 
medical professional. An atonic seizure first occurred at around 
4 years and 8 months of age. The patient later developed myo-
clonic seizures.
Upon admission, the patient’s weight was 21 kg (85th percen-
tile), his height was 111 cm (75th percentile), and his head cir-
cumference was 51 cm (50th percentile). Ataxia and poor muscle 
tone were observed. He also showed poor language development 
and inarticulate pronunciation of words, which suggested overall 
development delay.
Results of blood tests for complete blood cell count, routine 
biochemical analysis, and creatine kinase were within the normal 
range. However, the patient had lactic acidosis and increased 
lactate levels (2.3–4.8 mmol/L; normal value: below 2.1 mmol/L) 
in blood, as indicated by repeated testing. The plasma amino acid 
test had no specific findings, but lactic aciduria was observed in 
the urine organic acid test.
Electroencephalography of the patient showed epileptiform 
discharges, such as generalized sharp and wave discharges, but 
there were no specific findings on magnetic resonance imaging 
(MRI) (Figure 1). There was no lactate peak on magnetic reso-
nance spectroscopy. Cardiac function as assessed by echocardi-
ography was normal. Myopia and astigmatism were found on 
ophthalmologic examination, but no abnormalities were found 
in the optic nerve or retina. Right sensory neural hearing loss was 
identified using pure tone audiometry.
Myoclonus epilepsy with ragged-red fiber syndrome was sus-
pected based on the presence of characteristic clinical symptoms 
with repeated lactic acidosis. Specific tests were conducted to 
confirm mitochondrial etiology. Muscle biopsies were performed 
surgically from the quadriceps muscle and routine histo-
logical, immunohistochemical, and electron microscopic (EM) 
examinations were conducted. Light microscopic examination 
of muscle tissues revealed no RRFs. No abnormal findings were 
revealed using the modified Gomori trichrome or other special 
immunohistochemical staining procedures. Although increased 
numbers of mitochondria were noted in the myofilament and 
EM examination revealed megaconia, the characteristic find-
ings of mitochondrial myopathy were not observed (Figure 2). 
Biochemical assays to evaluate mitochondrial respiratory chain 
(MRC) enzyme activity were also performed. We observed 
decreased MRC complex I activity (below 10% of the reference 
range). Molecular genetic testing revealed the presence of the 
mitochondrial DNA A8344G mutation. The mutation burden 
was over 90%. Specimens were prepared from the patient’s mus-
cle, fibroblast, and blood. These specimens had burdens of 97, 95, 
and 90%, respectively (Table 1). In addition, mitochondrial DNA 
from the patient’s mother indicated the presence of a 75% muta-
tion burden in her blood. The patient had the clinical features 
of MERRF and the A8344G mutation, although no RRFs were 
observed using light microscopy (LM). The patient was finally 
diagnosed with mitochondrial disease.
DIsCUssIoN
The classical MERRF diagnostic criteria, described by Fukuhara 
et al. in 1980, included the following typical manifestations of the 
disease: myoclonus, generalized epilepsy, cerebellar ataxia, and 
RRFs detected using muscle biopsy (8). With recent develop-
ments in genetic testing, MERRF can be diagnosed on the basis 
of specific gene mutations even if RRFs are absent (5). In this case, 
we suspected MERRF based on clinical manifestations. However, 
since the typical RRFs were absent on biopsy, MERRF was only 
diagnosed using genetic analyses. The occasional absence of RRFs 
in patients with MERRF due to the A8344G mutation has been 
reported previously (9). In fact, Gignoux et al. have reported that 
RRFs and COX-negative fibers may emerge later in the course of 
the disease (9). In other words, RRFs may not be detected when 
the child is younger and may appear at later follow-ups. In this 
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case, the LM and immunohistochemical staining findings were 
normal, while EM revealed increased numbers of megaconia. 
Although this is not a characteristic finding of MERRF, it may 
suggest the presence of mitochondrial disease. Increased numbers 
of megaconia as detected using EM may be a significant finding in 
younger patients who do not exhibit RRFs in LM examinations. 
However, further studies are required to confirm this idea.
There is no positive correlation between the severity of clini-
cal findings and the mutated mtDNA burden (3). However, the 
results of one study suggest that the threshold for expression 
of COX-negative fibers is a 90% burden of mutated mtDNA in 
individuals with A8344G mutations (10). In this case, the muta-
tion burden in the patient’s blood specimen was 90% and that of 
his mother was 75%. Based on this observation, we can assume 
that the threshold for the expression of the A8344G gene muta-
tion is between 75 and 90%. In our patient, high proportions of 
mtDNA carrying the A8344G mutation were found in the skeletal 
muscle, in fibroblasts, and in blood. The mutation burdens of the 
various specimens were different, a finding that is consistent with 
the important concepts of heteroplasmy and tissue specificity in 
mitochondrial disease.
No reports specifying the age of symptom onset for MERRF 
have been published. Although the main manifestation in 
patients with mitochondrial disease is the presence of myoclonus 
and epilepsy, other multisystemic alterations, such as deafness, 
exercise intolerance, dementia, peripheral neuropathy, short 
stature, abnormal cardiac conduction, cardiomyopathies, oph-
thalmoparesis, pigmentary retinopathy, and lipoma have been 
reported (4, 6). Given the presence of these heterogeneous clinical 
features, we can generally suspect MERRF based on the presence 
of global developmental delay and myoclonic seizures. In cases of 
mitochondrial disease, integrated approaches for assessment and 
treatment, such as growth status examination, audiologic evalu-
ation, ophthalmologic evaluation, cardiac evaluation, assessment 
of cognitive ability, and physical therapy, are necessary. Such 
detailed assessments in patients with MERRF would help us to 
understand the natural course of the disease and to manage the 
patients with more care.
In this case, MRI findings at 4  years of age were normal. 
MRI performed 2 years later also revealed no specific findings. 
Conventional imaging studies of the brain, such as computed 
tomography or MRI, have confirmed that the gray matter is 
altered at an early stage in patients with MERRF, while changes 
in the white matter are more often observed in the later stages of 
the disease, and are never an isolated finding (11, 12). Cerebral, 
cerebellar, and brainstem atrophy occur as a result of progressive 
neuronal loss (4, 13, 14). Based on the patient’s MRI results, we 
can thus conclude that MRI does not provide definitive informa-
tion for the diagnosis of MERRF. However, since MRI results can 
change with age, further MRI assessments during the course of 
the disease are essential.
CoNClUsIoN
This study serves to illustrate the importance of molecular genetic 
analysis for the diagnosis of mitochondrial disease, especially 
in the absence of RRFs on muscle biopsy. Since the symptoms, 
pathological findings, and results of imaging studies are age-
dependent, we can construct a protocol based on these charac-
teristics to understand the disease’s natural course and to manage 
the patients more effectively. A diagnosis of MERRF should not 
be excluded even in cases without RRFs.
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